Clinical trials: Fistulae
Digestive Fistulae
Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
The purpose of the protocol, is to determine whether lanreotide 30 mg is effective in the treatment of patients with digestive fistulae.
- Trial name
- NCT00729313
- Testing
- Lanreotide microparticles
- Where
- 19 sites in France, Russia
- Volunteers
- 111 people
- Sponsor
- Ipsen
Obstructive Lesions of Arteriovenous Dialysis Fistulae
Study of NMB Drug Ejecting Balloon for Arteriovenous Fistulae
The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) for the treatment of obstructive lesions of Arteriovenous (AV) Dialysis Fistulae/Grafts.
- Trial name
- NCT01646788
- Testing
- NMB Paclitaxel Drug Ejecting Balloon
- Where
- Israel
- Volunteers
- 10 people
- Sponsor
- N.M.B. Medical Applications Ltd
Obstructive Lesions of Arteriovenous Dialysis Fistulae
Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae
The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) Balloon.
- Trial name
- NCT01538108
- Testing
- PTA Balloon catheter with paclitaxel, Plain Balloon angioplasty (PBA)
- Where
- Israel
- Volunteers
- 40 people
- Sponsor
- N.M.B. Medical Applications Ltd